Related Articles
Controlling serum uric acid using febuxostat in cancer patients at risk of tumor lysis syndrome
Reduced administration of rasburicase for tumor lysis syndrome: A single‑institution experience
Pharmacokinetics, immunogenicity and safety of bivatuzumab mertansine, a novel CD44v6-targeting immunoconjugate, in patients with squamous cell carcinoma of the head and neck
Phase I study of S-1 and biweekly docetaxel combination chemotherapy for advanced and recurrent gastric cancer
A PET study examining pharmacokinetics and dopamine transporter occupancy of two long-acting formulations of methylphenidate in adults